Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Identify and Report Duplicate Medication Orders

Houston, Texas Survey Completed on 04-09-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a licensed pharmacist accurately identified and reported drug regimen irregularities for a resident with multiple medication orders. Specifically, a male resident with quadriplegia and generalized anxiety disorder had two active orders for Buspirone 5 mg: one to be administered twice daily and another three times daily, both without end dates. Medication administration records showed that both orders were being followed concurrently, resulting in duplicate administration of the same medication. Despite the presence of duplicate orders, the consultant pharmacist's monthly drug regimen review did not identify or report this irregularity. The pharmacist stated that only the three times daily order was documented in her notes and denied awareness of the twice daily order, even though both were present in the facility's electronic medical record and being administered. Interviews with nursing staff and medication aides confirmed the existence of duplicate orders and acknowledged that the previous order should have been discontinued when the new one was entered. The facility's policies required new physician orders to be reviewed for accuracy during daily clinical meetings, but the duplicate orders for Buspirone were not identified or addressed until after the issue was brought to attention. The resident was alert and showed no signs of distress at the time of observation, and staff interviews indicated a lack of ongoing training regarding medication management for some personnel. The deficiency was identified through record review and staff interviews, highlighting a lapse in the facility's medication review and reporting processes.

An unhandled error has occurred. Reload 🗙